Previous 10 | Next 10 |
NEWTOWN, Pa., Sept. 22, 2022 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP reminds investors who purchased Enochian Biosciences Inc. (“Enochian” or the “Company”) (NASDAQ: ENOB) common stock between February 16, 2018, and June 27, 2022, inclusive (the ...
New York, New York--(Newsfile Corp. - August 15, 2022) - Levi & Korsinsky, LLP notifies investors in Enochian BioSciences, Inc. ("Enochian" or the "Company") (NASDAQ: ENOB) of a class action securities lawsuit. The lawsuit on behalf of Enochian investors has been commenced in the the Un...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Enochian To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - July 31, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, i...
NEW YORK, July 29, 2022 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Enochian Biosciences, Inc. (“Enochian Biosciences” or the “Company”) (NASDAQ: ENOB) in the United States District Court for the ...
NEW YORK, July 29, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP ( www.kaplanfox.com ) is investigating claims on behalf of investors of Enochian Biosciences, Inc. (NASDAQ: ENOB). A complaint has been filed on behalf of purchasers of Enochian securities between September ...
NEW YORK, NY / ACCESSWIRE / July 27, 2022 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Enochian Biosciences, Inc. ("Enochian" or the "Company") (NASDAQ:ENOB) and reminds investors of the September 26, 2022 deadline to seek the ...
NEW YORK, July 25, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Enochian Biosciences, Inc. (NASDAQ: ENOB), Corcept Therapeutics, Inc. (NASDAQ: CORT), Cassava Sciences, Inc. (NASDAQ: S...
LOS ANGELES, July 25, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB)—Today, Enochian BioSciences (the Company) announced that Dr. Richard (Rich) Whitley, M.D., of the University of Alabama at Birmingham (UAB), will become the Company’s Senior Scientific Advisor. A Distinguished Profe...
NEW YORK, July 20, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Enochian Biosciences, Inc. (NASDAQ: ENOB), Corcept Therapeutics, Inc. (NASDAQ: CORT), Rollins, Inc. (NYSE: ROL), and Wo...
NEW YORK, July 15, 2022 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Enochian Biosciences, Inc. (“Enochian” or the “Company”) (NASDAQ: ENOB ). The investigation concerns whether Enochian has violate...
News, Short Squeeze, Breakout and More Instantly...
Enochian Biosciences Inc. Company Name:
ENOB Stock Symbol:
NASDAQ Market:
LOS ANGELES, June 23, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB). Enochian BioSciences Inc., a company developing gene-modified cell immunotherapies for cancer and infectious diseases, wishes to advise that its 2023 Annual Stockholder Meeting (the “Annual Meeting”), which was sched...